Moximed springs to $33m Series B round

Moximed says it pulled in a $33 million Series B round for its joint-unloading KineSpring knee implant.

Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.

GBS Venture Partners, Gilde Healthcare Partners, Morgenthaler Ventures, Moximed, New Enterprise Associates, Vertex Venture Holdings

News Well, Funding Roundup, Implants, Knees, Orthopedics

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1KON1Y1